Posts by Sandra Ansanay-Alex
Superlab Suisse Lausanne
A coworking space designed for scientists Located in the Biopôle in Lausanne, Superlab Suisse offers ready to move in laboratory spaces. Superlab Suisse’s «Lab as a Service» business concept includes innovatively designed laboratory facilities, state-of-the-art equipment, professional and concierge services, as well as financing support for companies in the biotech, pharma, and medtech sectors.…
Read MoreUNIGE: Fighting breast cancer cells growth
A low rate of a specific protein triggers tumors development. A UNIGE team found the counter-attack In about 2/3 of breast cancers, the hormone estrogen facilitates tumor growth. A tamoxifen-based treatment inhibits tumors’ estrogen receptors to prevent their development. But 40 % of treated patients develop a resistance to the molecule. The laboratory of…
Read More$11 million for EPFL spin-off Leman Biotech
A protein that boosts the immune system can cure 90% of cancer in mice Immunotherapy, which aims to boost the patient’s immune system to fight cancer, has no effect in two out of three cases. After a while, T lymphocytes, the main players against cancer cells, become exhausted. To give them a new lease…
Read MoreGSK’s new company Haleon will have a site in Nyon
The pharmaceutical group GlaxoSmithKline creates Haleon, a new company from the separation of its consumer healthcare business. This entity will have a site in the commune of Prangins, part of the district of Nyon. The site currently employs 1,000 people in Prangins and produces 252 million units per year, including the medicines Voltaren and Otrivin.…
Read MoreNeo Medical raises $20 million for its AR technology for spine surgery
Swisscom Ventures is the lead investor in this round. The Vaud-based company will use the new funds to accelerate the commercial deployment of its artificial intelligence-supported augmented reality platform for spinal surgery. With a focus on the US market. Called Advise, the technology “provides surgeons with real-time intraoperative augmented reality (AR) visibility for the first…
Read MoreINTERVIEW : Massimo Nobile
🔺 Massimo Nobile, SwissBiotech Center CEO, explains how digital and life sciences are converging to create new medicines and treatments.
Read MoreMindMaze secures a $105 million financing round
After a banner-year, the Lausanne-based company MindMaze secures $105 Million Financing, led by Concord Health Partners, and initiates American Hospital Association Partnership MindMaze is a pioneer in the multibillion-dollar digital neurotherapeutics market and develops therapeutic solutions for a wide spectrum of neurological diseases. The financing was led by Concord Health Partners (“Concord”), a US-based…
Read MoreLeucine project: a new hub for life sciences in Lausanne
New working spaces at Biopôle Campus Lausanne Biopôle SA, in collaboration with CPEV, is developing the Leucine Building, a new multi-tenant space for companies active in life sciences. It will be operational early 2023. It consists of laboratory and office space that can be customised to its tenants’ needs. Three full floors of up to…
Read MorePhytlSigns raises CHF 500 000 for a plant monitoring system
The ‘Fitbit of Plants’ uses AI sensors to monitor crops The startup Vivent provides growers with a technology to monitor plants’ health and thereby improve both yield and sustainability. The CHF 500 000 Tech Growth loan from the Foundation for Technological Innovation (FIT) will fund the development and launch of a new plant monitoring…
Read MoreINTERVIEW : Raphaël Conz, BioAlps vice-president
🔺 Raphaël Conz, Head of the Business Unit at the Department for the Promotion of the Economy and Innovation of the Canton of Vaud (SPE). The talent of Switzerland, in the field of life sciences, is to bring together academic research and big companies’ interests.
Read More